Phlogenzyme

Replacement | Medicines | 28/06/2011

The marketing authorization holder informed its supplied customers in a letter dated June 28, 2011, that due to a minor deviation (falling below the specification limit) in the active ingredient activity of bromelain, the affected batch is being recalled as a precautionary measure.

Name of the medicinal product Phlogenzym - Filmtabletten
Marketing authorisation number(s) 1-22763
Marketing authorisation holder Mucos Pharma GmbH & Co.KG
Miraustraße 17, D-13509 Berlin

Vertrieb & Durchführung Austausch:
M.C.M. Klosterfrau Healthcare GmbH
Batch number(s) 99H073 (Packungen zu 40, 200 und 2x200 Stück)
Classification of the recall2
BASG reference number INS-640.001-0166
Email

Further inquiry note